{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-262867","form_type":"8-K","ticker":"NOVT","cik":"0001076930","company_name":"NOVANTA INC","filed_at":"2026-06-09T10:02:06+00:00","discovered_at":"2026-06-09T10:10:00.286857+00:00","generated_at":"2026-06-09T10:10:56.729648+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Novanta acquires Riverpoint Medical for $1.2B cash plus $250M milestone; recurring medical consumables to double","bullets":["Upfront cash consideration of $1.2B; milestone payment of $250M due Q1 2027.","Expected close Q3 2026, subject to HSR clearance and customary conditions.","Financing via cash on hand, existing credit facility, and $300M equity raise.","Riverpoint estimated 2027 Adjusted EBITDA ~$80M with synergies; upfront price ~19x 2026 EBITDA.","Medical consumables revenue to double to ~$300M; medical end-market to 60% of total revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-262867","json":"https://secwatch.observer/filing/0001193125-26-262867.json","markdown":"https://secwatch.observer/filing/0001193125-26-262867.md","text":"https://secwatch.observer/filing/0001193125-26-262867.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1076930/000119312526262867/0001193125-26-262867-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1076930/000119312526262867/novt-20260608.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T10:10:56.729648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"82fe1a4cb64e5aa04de8bcfd8add7060048e836c","claim":"NOVANTA INC entered into Equity Purchase Agreement with Runway Midco, LLC valued at $1,200,000,000 in cash (effective 2026-06-08).","evidence_excerpt":"On June 8, 2026, Novanta Inc., a Canadian corporation (the “ Company ”), Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“ Buyer ”), Novanta Corporation, a Michigan corporation (“ Intermediate Parent ”, and together with the Company and the Buyer, the “ Buyer Parties ”), Runway Midco, LLC, a Delaware limited liability company (“ Seller ”), and Runway Buyer, LLC, a Delaware limited liability company and direct wholly owned subsidiary of Seller (“ Runway Buyer ”), entered into an Equity Purchase Agreement (the “ Purchase Agreement ”), pursuant to which Buyer will acquire from Seller all of the issued and outstanding limited liability company interests (the “ Purchased Interests ”) of Runway Buyer (the “ Transaction ”). Transaction Consideration Subject to the terms and conditions of the Purchase Agreement, at the closing of the Transaction (the “ Closing ”), the Buyer Parties will pay Seller $1,200,000,000 in cash (the “ Closing Consi","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1076930/000119312526262867/0001193125-26-262867-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Runway Midco, LLC"},{"label":"Value","value":"$1,200,000,000 in cash"},{"label":"Effective","value":"2026-06-08"}],"fact_type":"material_agreement"},{"claim_id":"da72f1d704f29a88fcecb926696cf9304d73e62e","claim":"NOVANTA INC amended Third Amendment to Fourth Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent and lender, and the other lenders party thereto.","evidence_excerpt":"In connection with the Transaction, Intermediate Parent, the Company, and certain wholly-owned subsidiaries of the Company entered into the Third Amendment to Fourth Amended and Restated Credit Agreement (the “ Third Amendment ”), with Bank of America, N.A., as administrative agent and lender, and the other lenders party thereto, which amends that certain Fourth Amended and Restated Credit Agreement dated as of June 27, 2025 (as amended, the “ Credit Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1076930/000119312526262867/0001193125-26-262867-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Bank of America, N.A., as administrative agent and lender, and the other lenders party thereto"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}